Please assess the completion status of the following clinical trial:

Trial Title: Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Outpatient lumpectomy~* ASA I and II~* Age between 18-70~Exclusion:~* Pregnancy~* History of liver disease~* Unable to understand the informed consent~* Chronic pain with use of opioid in the last week~* Allergy to acetaminophen~Drop-out: surgeon or patient request

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- IV acetaminophen (Type: ACTIVE_COMPARATOR): Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
- Placebo (Type: PLACEBO_COMPARATOR): Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen

Based on this trial design, predict the completion outcome and termination type (if applicable).